The INS News
No Result
View All Result
  • Home
  • News
    • Regional
    • Srinagar
    • Jammu
    • National
    • World
  • Business & Economy
  • Multimedia
    • Photo Gallery
    • Video Gallery
  • Health
  • Jobs & Careers
  • Press Releases
  • Blog
  • Home
  • News
    • Regional
    • Srinagar
    • Jammu
    • National
    • World
  • Business & Economy
  • Multimedia
    • Photo Gallery
    • Video Gallery
  • Health
  • Jobs & Careers
  • Press Releases
  • Blog
No Result
View All Result
The INS News
No Result
View All Result
Home News Regional

Remdesivir unaffordable for Covid-19 patients: DAK

INS Desk by INS Desk
July 22, 2020
A A
Tobacco ban would prevent 40% cancer cases: DAK
Share on FacebookShare on TwitterWhatsappTelegramEmail

Srinagar, July 22: While antiviral drug remdesivir reduces the risk of death among Covid-19 patients, Doctors Association Kashmir (DAK) on Wednesday said the drug is unaffordable for poor patients.
“Because of high cost, remdesivir is out of reach for poor people” said DAK President and influenza expert Dr Nisar ul Hassan.
“The Central Drugs Standard Control Organization (CDSCO) has approved remdesivir injection under emergency use authorization for the treatment of suspected or lab confirmed Covid-19 cases who are hospitalized with severe disease,” he said.
“It is a five day treatment. The loading dose of 200 mg (shot) on day 1 is followed by 100 mg (shot) daily for 4 days (total 5 days),” he added.
Dr Nisar said each vial of remdesivir costs between Rs 4,000 to Rs 5,400. Thus for a five day treatment, a patient has to pay anywhere between Rs 24,000 and Rs 32,400 as the cost the drug.
“The price makes it inaccessible to those patients who desperately need it,” he said.
Dr Nisar said besides affordability, non-availability of the drug is equally breeding the concern on the ground.
“Unaffordability and non- availability of the drug is putting lives of Covid patients at serious risk,” he said.
Dr Nisar said government needs to make sure any treatment that has the potential to save lives is accessible and affordable to all those who need it,” he said.
“We must remove all obstacles to the widespread use of one of the most effective treatments that the novel virus has at this point in time,” he said.
Dr Nisar said studies have shown that patients who received remdesivir recovered faster than those who did not receive the drug.
Quoting a study, he said the drug cuts the recovery time by nearly one-third, reducing the median recovery time for Covid-19 patients by four days.
“Another clinical trial has found the drug to reduce the risk of death by 62% among Covid patients,” said Dr Nisar.

RELATED POSTS

MeT predicts rain, thunderstorm till tomorrow

Eid-ul-Azha: JKCSF-JKPUF urge timely redressal of public, education, welfare sector issues

Speaker to discuss functioning of House Committees tomorrow

Buy JNews
ADVERTISEMENT
Previous Post

SKIMS installs sophisticated machinery for conducting Plasmapheresis

Next Post

Markets to open for 3-days from July 28 in phased manner: Div Com

INS Desk

INS Desk

Related Posts

Weather to remain cloudy till Oct 28
Regional

MeT predicts rain, thunderstorm till tomorrow

June 2, 2025
JKCSF hopes for comprehensive overhaul of J&K’s education system
Regional

Eid-ul-Azha: JKCSF-JKPUF urge timely redressal of public, education, welfare sector issues

June 2, 2025
Veteran NC leader Rahim Rather set to be elected as Speaker
Regional

Speaker to discuss functioning of House Committees tomorrow

June 1, 2025
AEJAK, ASMEA present memorandum of demands to LG Sinha
Regional

AEJAK, ASMEA present memorandum of demands to LG Sinha

May 31, 2025
J&K has immense opportunity in tourism sector: PM Modi
Regional

‘Operation Sindoor’ India’s biggest anti-terror success: PM Modi in Bhopal

May 31, 2025
Take stern action against those violating law: IGP
Regional

Proper security in place for Kheer Bhawani mela: IGP Kashmir

May 31, 2025
Next Post
I&FC installs 9 automatic WLRs to record Jhelum, major tributaries water level

Markets to open for 3-days from July 28 in phased manner: Div Com

453 new covid-19 infections in J&K, total 15711

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *




Sopore shuts on trade body’s call

Sopore shuts on trade body’s call

January 3, 2018

Chinar Colony Narbal Gets Water After Six Days

March 28, 2023
Hurriyat (M) condemns use of force against students

Hurriyat (M): Now raising voice against braid chopping is crime in Kashmir

October 6, 2017

About

Indian News Service (INS) is the first registered online news portal from the state of Jammu & Kashmir. Our creative team consists of like-minded and socially concerned team of media professionals who carry decades of experience in their field of profession at their back. Our core values have pillars in honesty, empathy, credibility, equality and integrity.

More

© 2022 INS News - Designed by GITS.

No Result
View All Result
  • Home
  • News
    • Regional
    • Srinagar
    • Jammu
    • National
    • World
  • Business & Economy
  • Multimedia
    • Photo Gallery
    • Video Gallery
  • Health
  • Jobs & Careers
  • Press Releases
  • Blog

© 2022 INS News - Designed by GITS.